Wells Fargo Upgrades Charles River Labs (CRL) to Outperform on Major Sell-Off
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $280.05 -0.43%
Rating Summary:
23 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
23 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wells Fargo upgraded Charles River Labs (NYSE: CRL) from Market Perform to Outperform with a valuation range of $40-$42, saying shares are oversold following Wednesday's 9% swoon on guidance.
The firm comments, "We are upgrading shares of CRL to Outperform from Market Perform following the company's 2013 guidance announcement yesterday (12/12). We think shares are oversold after a 9% decline (vs. an increase of 0.04% in the S&P 500), given that the guidance midpoint is only 5% below consensus. We also think guidance is conservative based on (1) our modeling of FX, (2) accretion from Vital River, and (3) potential upside from partnerships. We believe this is a good entry point because we think 2013 could be the beginning of a slow improvement in the preclinical portion of the market."
The firm cut 2012E/2013E EPS to $2.69/$2.90 from $2.72/$2.99 previously.
For an analyst ratings summary and ratings history on Charles River Labs click here. For more ratings news on Charles River Labs click here.
Shares of Charles River Labs closed at $35.65 yesterday.
The firm comments, "We are upgrading shares of CRL to Outperform from Market Perform following the company's 2013 guidance announcement yesterday (12/12). We think shares are oversold after a 9% decline (vs. an increase of 0.04% in the S&P 500), given that the guidance midpoint is only 5% below consensus. We also think guidance is conservative based on (1) our modeling of FX, (2) accretion from Vital River, and (3) potential upside from partnerships. We believe this is a good entry point because we think 2013 could be the beginning of a slow improvement in the preclinical portion of the market."
The firm cut 2012E/2013E EPS to $2.69/$2.90 from $2.72/$2.99 previously.
For an analyst ratings summary and ratings history on Charles River Labs click here. For more ratings news on Charles River Labs click here.
Shares of Charles River Labs closed at $35.65 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Upgrades FOX Corp. (FOXA) to Overweight
- Kepler Cheuvreux Upgrades Komax Holding AG (KOMN:SW) to Buy
- TD Cowen Upgrades Northland Power Inc. (NPI:CN) (NPIFF) to Buy
Create E-mail Alert Related Categories
Analyst EPS Change, UpgradesRelated Entities
Standard & Poor's, Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
